ASPIRE (Acid Suppression Pharmacotherapy in the ICU: Re-evaluating the Evidence)
is an educational initiative intended to inform physicians, pharmacists and allied healthcare professionals of the latest therapeutic approaches and guidelines for the management of patients hospitalized with conditions such as peptic ulcer rebleeding and stress-related mucosal disease. These conditions affect the majority of the 4 million patients presenting to the ICU each year.

Presentations and discussions as presented in St. Louis, Missouri on February 26, 2005.

Sponsor Information
A continuing medical and pharmacy education program presented by the University of Michigan Medical School and the University of Michigan College of Pharmacy.